GlassScriptPhysician profile
Manal I Abdelhack
NPI 1285350777
$3,184.04
in general payments reported to CMS, 2019-2025
24 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.21 · 2023: $686 · 2024: $1,152 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,167.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,172.90 | 2023-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $468.14 | 2023-2025 | Nucala, Trelegy Ellipta |
| Amgen INC. | $141.65 | 2023-2025 | Tezspire |
| Insmed, INC. | $138.40 | 2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $114.94 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.25 | 2023-2025 | Ofev |
| Inspire Medical Systems, INC. | $106.00 | 2024-2025 | Inspire |
| Genzyme Corporation | $104.01 | 2024-2025 | |
| United Therapeutics Corporation | $97.51 | 2023-2025 | Tyvaso, Tyvaso |
| Pulmonx Corporation | $83.29 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Mallinckrodt Hospital Products INC. | $81.59 | 2023-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $78.57 | 2024-2025 | Cuvitru, Glassia |
| Verona Pharma, INC. | $73.79 | 2025 | Ohtuvayre |
| Edwards Lifesciences Corporation | $55.26 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Axsome Therapeutics, INC. | $50.06 | 2023 | Sunosi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $48.45 | 2024-2025 | Winrevair |
| Harmony Biosciences LLC | $46.26 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.12 | 2024 | |
| Baxter Healthcare | $42.36 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $42.01 | 2023 | Yupelri |
| Philips North America LLC | $26.80 | 2023 | |
| Zoll Respicardia, INC. | $21.17 | 2025 | Remede System |
| Electromed, INC. | $19.63 | 2025 | Smartvest |
| Resmed Corp | $16.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manal Abdelhack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.